eurodynamic and active release technique effects in carpal tunnel syndrome
Phase 3
- Conditions
- Carpal tunnel syndrome.Carpal tunnel syndromeG56.0
- Registration Number
- IRCT20230731058990N4
- Lead Sponsor
- niversity of Lahore, Lahore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Age is between 25-50 years
Both gender
Complaints of pain, numbness or tingling in the first three digits
Positive Phalen’s Sign
Unilateral Compression of Nerve
Exclusion Criteria
History of Carpal Tunnel Release Surgery
Patients with median nerve involvement in proximal areas such as thoracic outlet syndrome, cervical radiculopathy
Steroid injection in the carpal tunnel, thenar muscle atrophy
Metabolic diseases such as diabetes, severe thyroid disorders, anemia and pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pper-extremity disability and symptoms. Timepoint: Baseline, 4th week and 8th week of treatment. Method of measurement: Disabilities of the arm, shoulder and hand (DASH) questionnaire.;Symptom severity. Timepoint: Baseline, 4th week and 8th week of treatment. Method of measurement: Symptoms Severity Scale.
- Secondary Outcome Measures
Name Time Method Quality of Life. Timepoint: Baseline, 4th and 8th week of treatment. Method of measurement: Short Form-12.